Results 91 to 100 of about 1,148,813 (206)
Principles of portal hypertension treatment at patients with liver cirrhosis
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2012 The aim of review. To describe modern principles of portal hypertension treatment in patients with liver cirrhosis (LC).Original positions. One of the most significant LC complications is portal hypertension - acute bleeding from varicose veins (VV) of ...
Ye. A. Fedosina +2 more
doaj
Acta Médica del Centro, 2016 Hepatorenal syndrome is a condition that occurs in patients with chronic liver disease characterized by portal hypertension and it is distinguished by the deterioration of renal function and marked abnormalities in blood circulation, with activation of ...
Raysa Garay Padrón +2 more
doaj
Long‐Term Albumin Therapy in Cirrhosis With Ascites: Not an Answer yet
United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
Adrià Juanola, Pere Ginès
wiley +1 more source
Cardiac Output Changes in Hepatorenal Syndrome
, 2020 Background: Recent studies suggest that the development of hepatorenal syndrome occurs in the setting of a reduction in cardiac output, indicating that the progression of circulatory and renal dysfunction in cirrhosis is caused not only by splanchnic ...
Khaled El Karmouty +3 more
core
Iranian Journal of Public Health, 2018 Background: We aimed to explore risk factors for patients with liver cirrhosis complicated with spontaneous bacterial peritonitis (SBP). Methods: The clinical data of 195 patients with liver cirrhosis complicated with SBP (study group), admitted from ...
Yuan WANG, Qingyu ZHANG
doaj
The Egyptian Journal of Internal MedicineAim This study aims to compare the effectiveness of the model for end-stage liver disease (MELD), the modified model for end-stage liver disease including sodium (MELD-Na), and the Child–Pugh score (CPS) in predicting complications in patients with ...
Anagha Ravinath Naik, Swathy Moorthy
doaj +1 more source
Terlipressin for Hepatorenal Syndrome: Novel Strategies and Future Perspectives
, 2011 Type 1 hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Type 1 HRS develops as the consequence of a severe reduction of effective circulating volume due to both extreme splanchnic arterial
P. Angeli, Angeli P.
core +1 more source
Arquivos de GastroenterologiaBackground - Terlipressin and noradrenaline are the best studied treatments for hepatorenal syndrome, and there is no evidence of superiority of one over the other regarding to efficacy.
Ângelo Zambam de MATTOS +2 more
doaj +1 more source
Journal of University Medical & Dental CollegeBACKGROUND & OBJECTIVE: Hyponatremia, an electrolyte imbalance, is prevalent in decompensated chronic liver disease (DCLD) and is linked to an increased risk of complications, including hepatic encephalopathy, ascites, hepatorenal syndrome, and variceal ...
Toqeer Ahmad +5 more
doaj +1 more source
Hepatorenal syndrome in patients with postraumatic pancreatitis
, 2009 В роботі представлено аналіз розвитку ГРС у 580 хворих на гострий післятравматичнний панкреатит. Приведені клінічні та лабораторні зміни та їх залежність від ступеня тяжкості.
Сивожелізов, А.В. +4 more
core